http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09100237-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c31d756b30e9f6fe84a8d02899191b6c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 1995-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_788c2db2597ee66144abdd522e505268 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_283d9b82287f21a330ccd9f6ed061266 |
| publicationDate | 1997-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09100237-A |
| titleOfInvention | Blood flow improver |
| abstract | (57) [Summary] [Solution] The following general formula (1): H-His-Ser-Asp-AB-Phe-Thr-Asp-C-Tyr-D-Arg-E-Arg-F-Gln -G -Ala-Val- I -J -Tyr-Leu-K -L -M -Leu-N (1) (A is Ala or Gly; B is Ile or Val; C is Asn or Ser; D is Thr or Ser; E is Leu or Tyr; F, I and J are Lys or Arg respectively, but at least one of F, I and J is Arg; G is Met, Leu or Nle; K is Asn or Ala; L is Ser or Ala; M is Ile or Val; N is -NH 2 or Asn-NH 2 . However, at the same time, A is Ala and B Is Val, C is Asn, D is Thr, E is Leu, K is Asn, L Is Ser, M is Ile, and N is Asn-NH 2 . ) A blood flow improving agent containing the peptide represented by the formula (4) or a pharmaceutically acceptable salt thereof as an active ingredient. [Effect] It has an excellent effect of increasing blood flow. |
| priorityDate | 1995-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 298.